Oxitan Infusion
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Oxaliplatin (100mg)
Overview Oxitan Infusion
Colorectal cancer is treated with the intravenous infusion of Oxitan. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue use only as directed by your physician. Common side effects include nausea, fatigue, vomiting, and diarrhea. Oxitan can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions are possible; report any lip sores, mouth ulcers, rash, itching, or breathing difficulties immediately. Regular blood tests are mandatory to monitor blood cell counts, as well as heart, liver, and uric acid levels. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications before commencing treatment. Interactions with other medications are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding. It can induce male infertility; sperm banking should be discussed with your doctor prior to treatment. Driving is discouraged due to potential dizziness.
Uses of Oxitan Infusion
Colorectal cancer
Major Benefits of Oxitan Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Oxitan Infusion:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxitan Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Oxitan Infusion works:
Oxitan Infusion, an anti-neoplastic agent, inhibits cancer cell proliferation by targeting and disrupting their nucleic acids (DNA and RNA), thus halting their growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oxitan Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxitan Infusion during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Oxitan Infusion while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Oxitan Infusion. Oxaliplatin treatment carries a heightened risk of dizziness, nausea, vomiting, and other neurological symptoms impacting gait, potentially affecting the ability to drive safely.
KidneyCAUTION
For individuals with severe kidney impairment, Oxitan Infusion requires careful administration, and dosage modification may be necessary. Consult your physician for guidance. Data regarding Oxitan Infusion use in such patients is limited. No dosage changes are suggested for those with mild or moderate kidney disease.
LiverCAUTION
For patients with hepatic impairment, Oxitan Infusion requires careful administration. Dosage modification of Oxitan Infusion may be necessary. Physician consultation is advised.
What if you forget to take Oxitan Infusion :
Omit a dose of Oxitan Infusion? Seek medical advice immediately.
Facts to Know About Oxitan Infusion
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-based Anticancer Agents |
3,018 People bought this recently